BioMarin Pharmaceutical Inc
LSE:0HNC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
BioMarin Pharmaceutical Inc
LSE:0HNC
|
US |
|
TROPHY GAMES Development A/S
F:4H7
|
DK |
|
R
|
Radici Pietro Industries & Brands SpA
MIL:RAD
|
IT |
|
Wipro Ltd
NYSE:WIT
|
IN |
|
N
|
National Australia Bank Ltd
F:NAL
|
AU |
|
S
|
Sixt SE
XMUN:SIX2
|
DE |
|
Brunswick Corp
NYSE:BC
|
US |
|
C
|
Cohort PLC
F:C7K
|
UK |
|
Gillanders Arbuthnot & Co Ltd
NSE:GILLANDERS
|
IN |
|
M
|
Mitsubishi Materials Corp
SWB:MUJ
|
JP |
|
Minebea Mitsumi Inc
F:MEA0
|
JP |
|
Scentre Group
ASX:SCG
|
AU |
|
Kirin Holdings Co Ltd
F:KIR0
|
JP |
|
IVE Group Ltd
ASX:IGL
|
AU |
|
C
|
CNH Industrial NV
DUS:37C
|
UK |
|
Verisk Analytics Inc
F:VA7A
|
US |
|
Fomento de Construcciones y Contratas SA
OTC:FMOCF
|
ES |
|
Nongfu Spring Co Ltd
OTC:NNFSF
|
CN |
|
Bank of Communications Co Ltd
OTC:BCMXY
|
CN |
|
MetalQuest Mining Inc
F:E7Q
|
CA |
|
S
|
Sumitomo Realty & Development Co Ltd
F:RL2
|
JP |
|
C
|
Cresud SACIF y A
BCBA:CRES
|
AR |
|
Implenia AG
F:I8T
|
CH |
|
Cash Converters International Ltd
F:UKC
|
AU |
Intrinsic Value
Is 0HNC undervalued or overvalued?
See the intrinsic value estimate for 
BioMarin Pharmaceutical Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What BioMarin Pharmaceutical Does
BioMarin Pharmaceutical makes prescription medicines for rare genetic diseases, especially conditions that affect children and often need lifelong treatment. Its products include enzyme replacement therapies, biologic drugs, and gene therapies designed to treat the underlying cause of certain inherited disorders rather than just easing symptoms.
- Headquarters
- United States of America US
- Employees
- 3 221
- IPO date
- Jul 23, 1999
BioMarin Pharmaceutical has a narrow economic moat
Patents and rare-disease approval protections make it harder for rivals to copy some of BioMarin’s medicines, helping it keep customers in patient groups with few approved treatment options. The protection varies by medicine, and some products already face alternatives.
Read the full moat analysis
Revenue & Expenses Breakdown
BioMarin Pharmaceutical Inc
Earnings Waterfall
BioMarin Pharmaceutical Inc
The intrinsic value for BioMarin Pharmaceutical Inc (0HNC) under the Base Case is hidden USD.
Compared with the current market price of 58.19 USD, the stock appears hidden.